Operating Income (Loss) in USD of PLUS THERAPEUTICS, INC. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
PLUS THERAPEUTICS, INC. quarterly/annual Operating Income (Loss) history and change rate from Q2 2010 to Q3 2025.
  • PLUS THERAPEUTICS, INC. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$4.48M, a 18% decline year-over-year.
  • PLUS THERAPEUTICS, INC. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$13.5M, a 8.17% increase year-over-year.
  • PLUS THERAPEUTICS, INC. annual Operating Income (Loss) for 2024 was -$14.7M, a 10.3% decline from 2023.
  • PLUS THERAPEUTICS, INC. annual Operating Income (Loss) for 2023 was -$13.3M, a 32.4% increase from 2022.
  • PLUS THERAPEUTICS, INC. annual Operating Income (Loss) for 2022 was -$19.7M, a 57.8% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

PLUS THERAPEUTICS, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$13.5M -$4.48M -$683K -18% 01 Jul 2025 30 Sep 2025 10-Q 30 Oct 2025
Q2 2025 -$12.8M -$1.54M +$2.16M +58.4% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 -$14.9M -$3.54M -$237K -7.18% 01 Jan 2025 31 Mar 2025 10-Q 30 May 2025
Q4 2024 -$14.7M -$3.9M -$42K -1.09% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025
Q3 2024 -$14.7M -$3.8M -$548K -16.9% 01 Jul 2024 30 Sep 2024 10-Q 30 Oct 2025
Q2 2024 -$14.1M -$3.7M -$2.21M -148% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025
Q1 2024 -$11.9M -$3.3M +$1.42M +30.1% 01 Jan 2024 31 Mar 2024 10-Q 30 May 2025
Q4 2023 -$13.3M -$3.86M +$1.71M +30.8% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 -$15M -$3.25M +$1.84M +36.2% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$16.9M -$1.49M +$3.63M +70.9% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 -$20.5M -$4.72M -$796K -20.3% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$19.7M -$5.57M -$1.63M -41.5% 01 Oct 2022 31 Dec 2022 10-K 05 Mar 2024
Q3 2022 -$18.1M -$5.09M -$1.6M -45.6% 01 Jul 2022 30 Sep 2022 10-Q 31 Oct 2023
Q2 2022 -$16.5M -$5.12M -$2.55M -98.8% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023
Q1 2022 -$13.9M -$3.93M -$1.45M -58.4% 01 Jan 2022 31 Mar 2022 10-Q 20 Apr 2023
Q4 2021 -$12.5M -$3.94M -$544K -16% 01 Oct 2021 31 Dec 2021 10-K 23 Feb 2023
Q3 2021 -$11.9M -$3.5M -$2.1M -151% 01 Jul 2021 30 Sep 2021 10-Q 20 Oct 2022
Q2 2021 -$9.85M -$2.58M -$223K -9.48% 01 Apr 2021 30 Jun 2021 10-Q 21 Jul 2022
Q1 2021 -$9.62M -$2.48M -$38K -1.56% 01 Jan 2021 31 Mar 2021 10-Q 21 Apr 2022
Q4 2020 -$9.58M -$3.4M -$1.18M -53.5% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022
Q3 2020 -$8.4M -$1.4M -$4.08M -152% 01 Jul 2020 30 Sep 2020 10-Q 21 Oct 2021
Q2 2020 -$4.33M -$2.35M -$393K -20.1% 01 Apr 2020 30 Jun 2020 10-Q 22 Jul 2021
Q1 2020 -$3.93M -$2.44M -$275K -12.7% 01 Jan 2020 31 Mar 2020 10-Q 22 Apr 2021
Q4 2019 -$3.66M -$2.21M -$393K -21.6% 01 Oct 2019 31 Dec 2019 10-K 22 Feb 2021
Q3 2019 -$3.26M $2.68M +$4.91M 01 Jul 2019 30 Sep 2019 10-Q 22 Oct 2020
Q2 2019 -$8.17M -$1.96M -$113K -6.12% 01 Apr 2019 30 Jun 2019 10-Q 10 Aug 2020
Q1 2019 -$8.06M -$2.17M +$704K +24.5% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2020
Q4 2018 -$8.76M -$1.82M -$7.79M -130% 01 Oct 2018 31 Dec 2018 10-K 30 Mar 2020
Q3 2018 -$968K -$2.23M +$2.12M +48.7% 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2019
Q2 2018 -$3.08M -$1.85M +$3.74M +66.9% 01 Apr 2018 30 Jun 2018 10-Q 15 Aug 2019
Q1 2018 -$6.82M -$2.87M +$4.26M +59.7% 01 Jan 2018 31 Mar 2018 8-K 10 Sep 2019
Q4 2017 -$11.1M $5.98M +$9.56M 01 Oct 2017 31 Dec 2017 8-K 10 Sep 2019
Q3 2017 -$20.6M -$4.34M +$454K +9.46% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 -$21.1M -$5.58M +$643K +10.3% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 -$21.7M -$7.13M -$2.03M -39.9% 01 Jan 2017 31 Mar 2017 10-Q 11 May 2018
Q4 2016 -$19.7M -$3.59M -$1.51M -72.7% 01 Oct 2016 31 Dec 2016 10-K 09 Mar 2018
Q3 2016 -$18.2M -$4.8M -$6.79M -340% 01 Jul 2016 30 Sep 2016 10-Q 09 Nov 2017
Q2 2016 -$11.4M -$6.22M -$12M -207% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 $614K -$5.1M +$15.9M +75.7% 01 Jan 2016 31 Mar 2016 10-Q 12 May 2017
Q4 2015 -$15.3M -$2.08M +$2.24M +51.8% 01 Oct 2015 31 Dec 2015 10-K 24 Mar 2017
Q3 2015 -$17.5M $2M +$9.89M 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 -$27.4M $5.79M +$16.5M 01 Apr 2015 30 Jun 2015 10-Q 05 Aug 2016
Q1 2015 -$43.9M -$21M -$11.5M -120% 01 Jan 2015 31 Mar 2015 10-Q 10 May 2016
Q4 2014 -$32.4M -$4.32M +$4.8M +52.7% 01 Oct 2014 31 Dec 2014 10-K 11 Mar 2016
Q3 2014 -$37.2M -$7.89M +$571K +6.75% 01 Jul 2014 30 Sep 2014 10-Q 06 Nov 2015
Q2 2014 -$37.8M -$10.7M -$4.32M -67.9% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 -$33.5M -$9.55M -$2.81M -41.7% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$30.7M -$9.12M -$6.36M -230% 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016
Q3 2013 -$24.3M -$8.46M +$1.87M +18.1% 01 Jul 2013 30 Sep 2013 10-Q 07 Nov 2014
Q2 2013 -$26.2M -$6.36M +$597K +8.58% 01 Apr 2013 30 Jun 2013 10-Q 11 Aug 2014
Q1 2013 -$26.8M -$6.74M +$1.63M +19.5% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 -$28.4M -$2.76M +$3.21M +53.8% 01 Oct 2012 31 Dec 2012 10-K 16 Mar 2015
Q3 2012 -$31.6M -$10.3M -$2.51M -32.1% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 -$29.1M -$6.96M -$2.59M -59.2% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 -$26.5M -$8.37M +$2.88M +25.6% 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q4 2011 -$29.4M -$5.97M 01 Oct 2011 31 Dec 2011 10-K 14 Mar 2014
Q3 2011 -$7.82M +$1.77M +18.4% 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 -$4.37M +$670K +13.3% 01 Apr 2011 30 Jun 2011 10-Q 09 Aug 2012
Q1 2011 -$11.2M 01 Jan 2011 31 Mar 2011 10-Q 10 May 2012
Q3 2010 -$9.59M 01 Jul 2010 30 Sep 2010 10-Q 08 Nov 2011
Q2 2010 -$5.04M 01 Apr 2010 30 Jun 2010 10-Q 09 Aug 2011

PLUS THERAPEUTICS, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$14.7M -$1.37M -10.3% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025
2023 -$13.3M +$6.39M +32.4% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025
2022 -$19.7M -$7.22M -57.8% 01 Jan 2022 31 Dec 2022 10-K 05 Mar 2024
2021 -$12.5M -$2.91M -30.3% 01 Jan 2021 31 Dec 2021 10-K 23 Feb 2023
2020 -$9.58M -$5.93M -162% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022
2019 -$3.66M +$5.11M +58.3% 01 Jan 2019 31 Dec 2019 10-K 22 Feb 2021
2018 -$8.76M +$2.32M +20.9% 01 Jan 2018 31 Dec 2018 10-K 30 Mar 2020
2017 -$11.1M +$8.63M +43.8% 01 Jan 2017 31 Dec 2017 8-K 10 Sep 2019
2016 -$19.7M -$4.42M -28.9% 01 Jan 2016 31 Dec 2016 10-K 09 Mar 2018
2015 -$15.3M +$17.2M +52.9% 01 Jan 2015 31 Dec 2015 10-K 24 Mar 2017
2014 -$32.4M -$1.76M -5.73% 01 Jan 2014 31 Dec 2014 10-K 11 Mar 2016
2013 -$30.7M -$2.26M -7.96% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 -$28.4M +$994K +3.38% 01 Jan 2012 31 Dec 2012 10-K 16 Mar 2015
2011 -$29.4M -$4.09M -16.1% 01 Jan 2011 31 Dec 2011 10-K 14 Mar 2014
2010 -$25.3M 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.